Recursion Pharmaceuticals
is a simplified version of one of recursion internal compound intelligence tools a to illustrate what can be done with this data this is not our flagship internal map we are providing this tool for basic exploration of compound compound and compound gene relationships across approved and commercially available compounds all plots and driven by this single highlighting the power and flexibility of our based platform leading field in open science using | Recursion Pharmaceuticals
Company
Deck Type
Sector
Industry
Deck date
January 2023
Slide
76 of 143
Related slides by other companies
HeartBeam
Results
August 2023
product updates two planned submission for version hardware lead collection device version including algorithms that generate a synthesized for physician review status version submitted in may version to be submitted after clearance of the version system sub meeting scheduled with limited market release expected withdrew application for to focus on opportunity | HeartBeam
HeartBeam
Results
August 2023
closing summary financial closed significant funding round of million to enable company to execute on upcoming milestones strong cash position provides runway to late strategic focus and progress adjusted strategic focus to enable timely delivery of breakthrough ambulatory products submitted a application to the food and drug administration for the system version set sub meeting with for version validation foundational study on detection of coronary artery occlusions published in advances added three strong members to the board of directors added as vice president of regulatory patent granted for cardiac detection with system | HeartBeam
HeartBeam
Results
November 2023
steady progress toward key product milestones two submissions for version hardware lead collection device submitted in may received and responded to questions from version including algorithms that generate a synthesized for physician review to be submitted after clearance of the version system held submission meeting with focused on the design of the clinical study that will demonstrate the performance of our synthesized in relation to standard limited market release expected following clearance for version and version no change from last quarter guidance | HeartBeam
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io